Document is current
Any future updates will be listed below
-
Authors
Xourafa, Georgia https://orcid.org/0009-0008-1540-0310
Herder, Christian https://orcid.org/0000-0002-2050-093X
Roden, Michael
- License Information
-
More Information
Article History
Received: 8 April 2024
Revised: 9 July 2024
Accepted: 31 July 2024
First Online: 9 September 2024
Competing interests
: The authors declare the following competing interests: M.R. received lecture fees or served on advisory boards for AstraZeneca, Boehringer-Ingelheim, Echosens, Eli Lilly, Madrigal, MSD, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer-Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). G.X. and C.H. declare no competing interests.
